Irinotecan is a topoisomerase I inhibitor for LoVo cells and HT-29 cells with IC50 of 15.8 μM and 5.17 μM, respectively.Irinotecan hydrochloride has been used:in combination with 5-fluorouracil for screening growth inhibitory functionality in
Irinotecan is a topoisomerase I inhibitor for LoVo cells and HT-29 cells with IC50 of 15.8 μM and 5.17 μM, respectively.Irinotecan hydrochloride has been used:in combination with 5-fluorouracil for screening growth inhibitory functionality in
Irinotecan is a topoisomerase I inhibitor for LoVo cells and HT-29 cells with IC50 of 15.8 μM and 5.17 μM, respectively.Irinotecan hydrochloride has been used:in combination with 5-fluorouracil for screening growth inhibitory functionality in
Irinotecan is a topoisomerase I inhibitor for LoVo cells and HT-29 cells with IC50 of 15.8 μM and 5.17 μM, respectively.Irinotecan hydrochloride has been used:in combination with 5-fluorouracil for screening growth inhibitory functionality in
Irinotecan is a topoisomerase I inhibitor for LoVo cells and HT-29 cells with IC50 of 15.8 μM and 5.17 μM, respectively.Irinotecan hydrochloride has been used:in combination with 5-fluorouracil for screening growth inhibitory functionality in
Irinotecan is a topoisomerase I inhibitor for LoVo cells and HT-29 cells with IC50 of 15.8 μM and 5.17 μM, respectively.Irinotecan hydrochloride has been used:in combination with 5-fluorouracil for screening growth inhibitory functionality in